SHE:300636 - Jiangxi Synergy Pharmaceutical Co Ltd

Jiangxi Synergy Pharmaceutical
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q2	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	140.18M 2.1%	150.47M 7.3%	164.13M 9.1%	179.77M 9.5%	156.2M -13.1%	192.3M 23.1%	191.63M -0.3%	220.75M 15.2%	161.01M -27.1%	177.91M 10.5%	162.48M -8.7%	206.45M 27.1%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	97.78M -0.3%	103.04M 5.4%	114.36M 11.0%	124.61M 9.0%	116.82M -6.3%	131.99M 13.0%	113.03M -14.4%	141.52M 25.2%	112.98M -20.2%	130.07M 15.1%	97.09M -25.4%	130.75M 34.7%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.4M 8.0%	47.43M 11.9%	49.76M 4.9%	55.16M 10.8%	39.39M -28.6%	60.3M 53.1%	78.6M 30.3%	79.22M 0.8%	48.03M -39.4%	47.84M -0.4%	65.38M 36.7%	75.7M 15.8%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	113.62M 0.4%	123.94M 9.1%	142.16M 14.7%	148.02M 4.1%	140.01M -5.4%	158.64M 13.3%	149.04M -6.1%	175.6M 17.8%	141.25M -19.6%	154.29M 9.2%	128.38M -16.8%	152.54M 18.8%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	15.83M 5.3%	20.9M 32.1%	27.8M 33.0%	23.41M -15.8%	23.2M -0.9%	26.65M 14.9%	36.01M 35.1%	34.07M -5.4%	28.27M -17.0%	24.22M -14.3%	31.29M 29.2%	21.79M -30.4%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.57M 9.7%	26.53M -0.2%	21.97M -17.2%	31.75M 44.5%	16.19M -49.0%	33.66M 107.9%	42.59M 26.5%	45.15M 6.0%	19.76M -56.2%	23.62M 19.5%	34.09M 44.3%	53.91M 58.1%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.53M -	-	-	-	42.64M -	-	-	-	57.03M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	22.39M 11.2%	24.02M 7.3%	14.57M -39.3%	26.83M 84.1%	15.81M -41.1%	31.85M 101.4%	26.18M -17.8%	33.1M 26.4%	23.93M -27.7%	21.62M -9.7%	27.33M 26.4%	43.56M 59.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.072 11.0%	0.082 13.5%	0.043 -48.1%	0.087 103.5%	0.049 -43.2%	0.095 92.9%	0.077 -19.4%	0.095 23.0%	0.068 -28.5%	0.052 -22.8%	0.064 23.2%	0.104 61.3%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.061 -7.2%	0.074 22.3%	0.04 -45.6%	0.079 96.8%	0.047 -41.0%	0.095 103.6%	0.059 -37.9%	0.094 58.6%	0.068 -28.0%	0.052 -22.8%	0.064 23.2%	0.104 61.3%